Preliminary in vitro analysis has indicated that blocking CD70 or CD27 can mitigate Raji-specific T-cell activation, however, in vivo data with CD70 KO Raji cells indicated that T-cell-mediated tumor control is not solely dependent on the CD70-CD27 axis. This evidence concerns the gene CD70 and neoplasm.